SHARE Knowledge Hub

Toxic Peripheral Neuropathy

Toxic peripheral neuropathy means peripheral nerve damage linked to a toxic exposure, but symptoms alone do not establish the cause. For suspected poisoning or harmful chemical contact, get medical advice immediately even if the person seems well; use the GB or NI urgent route below. Call 999 for sudden stroke-like signs or a severe chemical emergency. For gradual new nerve symptoms, seek GP assessment. At work, stop uncontrolled exposure, identify the substance and task, and obtain competent control and health advice. Great Britain and Northern Ireland have separate COSHH and RIDDOR rules. This page is general learning, not a diagnosis or fitness decision.

Updated 2026-10-22GB and NI

Understanding Toxic Peripheral Neuropathy

Toxic peripheral neuropathy is peripheral nerve damage attributed to a toxic agent; symptoms alone do not establish an occupational cause.

Why this matters at work

Loss of sensation can be more hazardous than pain because injury goes unnoticed. Inspect feet, footwear and skin where advised clinically; address hot work, sharp edges, vibration, chemicals and walking surfaces. A worker with reduced protective sensation should not be assigned to thermal or cutting hazards on the assumption that gloves or boots compensate for inability to detect damage.

Substitution can fail if it exchanges a known product for a poorly characterised blend. Compare hazard class, neurotoxicity, volatility, flammability, skin penetration, quantity and method. Spraying, heated use and open wiping increase vapour generation; enclosed automated use can reduce routine exposure but create maintenance peaks. Validate the chosen method with exposure monitoring where uncertainty remains.

How organisations manage this in practice

The risk assessment and equipment performance determine additional checks; a current test sticker cannot validate a broken hood or bypassed interlock. Verify controls with smoke visualisation where safe, pressure or flow indicators, exposure monitoring, containment checks and worker observation.

New numbness, pain, weakness or altered balance needs healthcare assessment and a review of plausible exposures. Managers should recognise functional risk without diagnosing the cause. Record the task and timing and prevent further harmful exposure while concerns are assessed.

The occupational history should be chronological and task specific. Record employers and sites, products and CAS numbers, mixtures, quantities, application method, temperature, ventilation, PPE, skin contact, spills, cleaning, maintenance, symptom timing, co-worker illness and whether symptoms changed away from work. Include old jobs because neuropathy may follow cumulative or historic exposure.

Provide the SDS, COSHH assessment, monitoring and competent hygiene summary with consent and through the appropriate route; do not flood the referral with irrelevant records or ask the clinician to decide whether the organisation complied with law. A later legal process may need the original versions and dates.

Identify ingredients, process conditions and all exposure routes. A mixture may require more than separate comparisons with individual exposure limits. Use current product data and competent hygiene advice to evaluate combined effects and control failures.

NHS describes sensory loss, pain, balance problems and weakness as possible neuropathy symptoms and advises GP assessment. There are many causes, including non occupational ones. Workplace exposure investigation and clinical differential diagnosis answer different questions.

What is toxic peripheral neuropathy?

Peripheral neuropathy is damage to nerves outside the brain and spinal cord. Some chemical exposures can cause it, but symptoms alone do not identify the cause.

A practical decision route
  1. Verify the substance

    Use the current formulation and real task, not a generic solvent label.

  2. Control exposure

    Remove or substitute the product, then verify containment.

  3. Respond to concerns

    Stop uncontrolled exposure and arrange a confidential clinical route.

  4. Check effectiveness

    Compare observed work, exposure evidence and corrective action.

This is a reading route through the detailed decisions below, not a clearance to perform the task. Follow the linked sections, their official sources and the applicable local assessment.

Numbness, tingling, burning pain, weakness and loss of balance may occur. Diabetes, medicines, alcohol, injury and other conditions can also cause peripheral neuropathy. A GP or specialist assesses diagnosis and cause; an employer assesses and controls work exposure without waiting for a diagnosis.

HSE COSHH Essentials SR22 identifies n-hexane in solvent-based adhesives as a nerve-damage hazard and advises avoiding products that contain it. HSE also recognises that repeated exposure to particular solvents may cause neurological disease. Product identity, mixture, route, real duration, skin contact and existing controls matter more than a broad solvent label. Lead, asbestos and some pesticides can have separate regulatory routes; seek substance-specific advice.

Neither an SDS hazard phrase, a symptom report nor a single air sample proves toxic neuropathy. Record the concern, prevent further uncontrolled exposure and share an accurate exposure history with occupational health or the treating clinician through a confidential route.

Observation category (not a diagnosis)Possible symptom patternWorkplace relevance
Sensory nerve effectTingling, numbness, burning pain or altered sensation.May first be reported as pins and needles after solvent or metal work.
Motor nerve effectWeakness, reduced grip, foot drop, cramps or clumsiness.May affect tool use, ladders, driving, plant, manual handling or fine work.
Balance and coordinationUnsteady walking, slips or poor coordination.Could create secondary safety risk in safety-critical tasks.
Acute solvent effectDizziness, drowsiness, headache, confusion or nausea.May indicate harmful exposure or another urgent condition; stop the task, make the area safe and seek medical assessment. Symptoms alone do not prove cause or control failure.
Possible central nervous system effects, distinct from peripheral neuropathyPersistent memory, mood, concentration or nerve symptoms.Requires exposure history, OH/medical review and control investigation.
Delayed or progressive symptomsSymptoms may not stop immediately when a task ends.Do not dismiss symptoms because they are subtle or intermittent.

Separate peripheral and central effects

Peripheral sensory effects involve sensation; motor effects involve strength and movement; autonomic effects involve involuntary functions. Balance problems need clinical assessment and can have different causes. Acute intoxication (such as dizziness or drowsiness) and possible central effects on memory, mood or concentration are separate categories; they do not diagnose peripheral neuropathy. See Organic Solvent Encephalopathy for the separate central-effects lesson. Possible poisoning and stroke signs still follow the urgent routes below.

How does exposure become nerve injury?

Trace the actual substance from purchase and use through release, inhalation or skin contact, possible uptake and health concern; separate exposure evidence from a clinical diagnosis.

For each task identify product and ingredients, quantity, application, ventilation, contaminated surfaces, waste, frequency, duration and everyone exposed. Air sampling measures inhaled concentration for the sampled work; biological monitoring measures uptake; neither is a clinical diagnosis or a substitute for health surveillance.

Do not use odour or an open door as proof of safety. Check that enclosure or local exhaust ventilation (LEV) captures releases at source, skin contact is controlled and work-as-done matches the assessment. Where evidence is missing, hold the exposure-producing step until a competent person sets and verifies interim controls.

Pathway stageWhat to examineControl focus
Substance identitySDS, composition, trade name, impurities and degradation products.Substitute less hazardous products where possible.
Form and volatilityLiquid solvent, vapour, dust, aerosol or contaminated surface.Containment, LEV, closed transfer or wet methods.
Inhalation routeBreathing zone exposure during use, cleaning or drying.LEV, ventilation, enclosure and exposure monitoring.
Skin routeSplashes, soaked gloves, contaminated rags or tool handles.Glove material, breakthrough time, skin hygiene and task design.
Ingestion routeHand-to-mouth transfer, food or drink in work area.Welfare, handwashing, clean/dirty separation and no eating in contaminated zones.
Dose over timeFrequency, duration, peaks and cumulative exposure.WEL monitoring, biological monitoring where relevant and trigger-time control.
Health signalSymptoms, health surveillance or OH findings.Remove exposure, review controls and involve competent advice.

What should teams check before, during and after a neurotoxic exposure task?

Confirm the substance and task, prevent release and contact, verify controls in use, stop on uncertainty or symptoms, then document a safe hand-back.

Task, people and placeBefore workDuring work and hold pointAfter and evidence
Routine panel cleaning in a ventilated workshop; technicians and nearby staff.Confirm current product/SDS, safer alternative, bench capture, compatible gloves, closed rag bin and competent instruction.Check capture at the actual bench and prevent skin contact. Stop if vapour escapes, gloves fail or symptoms occur.Close waste, clean surfaces, record checks and any concern; reopen after a verified control fix.
Contractor coating removal in occupied refurbishment; contractor and client staff.Agree product, method, segregation, ventilation, access, emergency contacts and who owns the hand-back.Hold work if product changes, barriers fail or vapour reaches others; reassess before continuing.Inspect area, waste and residual contamination; exchange records and authorise hand-back.
Unlabelled cleaner or substituted product at stores; purchaser, user and others.Quarantine until identity, label and current SDS are confirmed; assess actual use and supply conditions.Do not trial an unknown liquid or infer glove compatibility from appearance.Approve and label only after competent review; retain product decision and supplier information.
LEV fault or unusual solvent use during maintenance; maintainer and operators.Isolate the exposure-producing task and plan a safe repair by competent people.Do not rely on open doors or a disposable mask; hold until source capture is demonstrated.Record repair, performance check and authorised restart under real task conditions.
Spill with worker symptoms; responders and nearby workers.Know emergency plan, first aid, isolation and product details before use.Evacuate/isolate as needed; call emergency help for serious symptoms. Do not send unprotected staff into vapour.Preserve facts, arrange competent clean-up, review exposure/health routes and verify safe hand-back.

How might toxic neuropathy develop in a solvent-cleaning task?

A vehicle repair bench-cleaning task illustrates why product identity, glove compatibility, capture and duration must be checked in real work.

At a repair shop, a technician repeatedly wipes panels with a solvent cleaner. The current safety data sheet (SDS) has not been checked; used rags remain open and thin gloves soften. The spray booth extraction does not necessarily capture vapour at the bench. These are exposure-control questions, not proof that any symptom was caused by work.

The supervisor pauses the bench task, offers a safe alternative and records the product, time and conditions. A competent assessor checks substitution, closed rags, suitable local capture, compatible gloves and the need for monitoring. A worker with new tingling seeks GP advice, with occupational health support and a factual exposure history. Restart only after controls are verified at the bench.

ObservationWeak interpretationStronger occupational health response
Task listed as occasionalExposure is low because the method statement says so.Observe real duration, frequency and work-as-done.
Solvent smell in areaSmell warns people to leave if it gets bad.Smell is not a reliable exposure indicator.
Disposable gloves softenAny glove is better than no glove.Select glove material by SDS and breakthrough time.
Tingling symptomsProbably unrelated or personal.Treat as potential health signal and review exposure.
No air monitoringNo evidence of a problem.Commission competent monitoring where WEL or exposure concern exists.
Worker moved temporarilyProblem solved.Review source, LEV, hygiene, waste and surveillance for the whole team.

Which agents and product routes need a separate nerve-risk assessment?

n-Hexane and acrylamide are documented nerve hazards; other listed product groups need their own evidence, authorisation and exposure assessment before attributing symptoms.

An ingredient name is a prompt to investigate, not a diagnosis. Check the current SDS, process-generated substances, applicable GB or NI regime and credible exposure routes. Use the applicable UK substance assessment and exposure limits; a foreign limit does not replace them.

For lead, use the separate lead-at-work route; for pesticides, check the applicable product authorisation and use rules as well as health controls. Specialist review is needed where mixtures, unknowns or symptoms make the assessment uncertain.

Agent or groupTypical workplace contextControl emphasis
n-HexaneSome adhesives, cleaners and degreasing products if actually present in the formulation.Check the SDS and substitute n-hexane where present; HSE SR22 identifies nerve damage in small-scale adhesive work. Verify the actual formulation and GB or NI controls.
Other solvent mixturesPainting, coating and cleaning with variable ingredients.Identify each product and task; HSE warns of possible long-term neurological disease for some solvents.
Lead and its compoundsLegacy paint, battery or specialist processes.Use the separate lead-at-work rules and competent medical-surveillance advice; do not treat as ordinary COSHH-only work.
Acrylamide or specialist chemicalsIndustrial or laboratory work where the ingredient is confirmed.Seek substance-specific occupational hygiene and clinical advice; do not infer risk from a generic list.
Pesticide productsAuthorised pest-control or agricultural use.Check actual formulation, authorisation, label and applicable regime; do not imply all pesticides cause neuropathy.

What should happen when symptoms are reported?

Suspected poisoning or harmful chemical contact needs immediate medical advice even without severe symptoms; sudden stroke signs or serious illness need 999. Gradual new nerve symptoms need GP assessment and a separate workplace control review.

If a substance may have been swallowed, inhaled or contacted the skin, stop exposure and make the area safe without an unprotected rescue. In England and Wales, NHS poisoning advice says call 999 or go to A&E for suspected harmful swallowing, touch or inhalation, even if symptoms are absent; use NHS 111 promptly if unsure whether the substance is harmful. In Scotland, NHS inform says call 999 for known swallowed poison; seek urgent GP/NHS 24 on 111 advice for other suspected harmful touch or inhalation, and call 999 for serious illness. In Northern Ireland, nidirect says get medical help immediately: call a GP or GP out-of-hours service if the person appears well, and go to an emergency department if prompt advice is unavailable and the substance may be hazardous. Call 999 for severe illness or breathing difficulty. Do not wait for symptoms, which can be delayed. Call 999 for sudden one-sided weakness, face droop or speech change, even if it improves. Share the container or SDS with clinicians if safely available; do not delay care to find it. Gradual unexplained tingling without an acute exposure needs GP assessment.

The supervisor records the concern without demanding a diagnosis, holds any uncontrolled exposure and any affected safety-critical task, and seeks competent advice. Consider co-workers sharing the exposure. A clinician decides the medical workup; the employer fixes exposure controls and respects confidentiality.

TriggerImmediate controlFollow-up
Sudden face, arm or speech changeCall 999 now; do not drive the person to A&E.NHS stroke route; secure the work area separately.
Suspected harmful chemical contact, inhalation or swallowing, even if wellStop exposure safely. England/Wales: 999 or A&E for suspected harmful contact; NHS 111 if unsure. Scotland: 999 for known swallowed poison or serious illness; urgent GP/NHS 24 on 111 advice for other suspected harmful contact or inhalation. NI: GP/GP out of hours immediately if well; emergency department if prompt advice unavailable. 999 for severe illness.No unprotected rescue; share product/SDS with clinicians without delaying care. Symptoms can be delayed.
New tingling, pain, numbness or weaknessArrange GP assessment and pause uncontrolled exposure.Worker, supervisor and occupational health; factual exposure history.
Balance or grip change in safety-critical workHold the affected task pending task-specific review.Manager and OH/clinician; no blanket fitness rule.
More than one worker reports symptomsCheck the shared process and controls without diagnosing the group.Competent COSHH and occupational hygiene review.

How should clinical concerns and workplace controls be kept separate?

Clinicians diagnose and advise on health; the workplace controls exposure, documents the task and implements proportionate task-specific advice.

A GP may investigate diabetes, medicines, injury and other causes as well as possible toxic exposure. Occupational health may advise on work impact and surveillance. Managers need the functional advice and controls, not an unrestricted clinical record.

Exposure monitoring tests airborne concentration or uptake; health surveillance looks for early work-related health effects where the regulatory criteria apply. They answer different questions. Keep individual health data restricted, with an identified lawful basis and special-category condition; share only what the manager needs for control and adjustment.

IssueClinical boundaryOccupational control action
Symptoms and causeGP or specialist assesses diagnosis and differential causes.Manager records task facts and prevents uncontrolled exposure.
Exposure monitoringHygienist interprets air or biological exposure data.Act on control findings; do not treat a sample as a diagnosis.
Health surveillanceCompetent OH professional designs and interprets the appropriate scheme.Employer provides it when criteria apply and closes control actions.
Fitness for a taskOH/clinician gives relevant functional advice where needed.Manager reviews the actual task and temporary controls; no universal threshold.
Private health informationClinical details remain in the protected health route.Share only necessary work-impact advice with authorised people.

Control the task and investigate the concern on separate tracks

Identify the exact substance and exposure route while arranging appropriate confidential assessment of symptoms. Neither a symptom pattern nor a single air sample establishes toxic causation.

Local extraction and chemical containers at a workplace assessment station. Photorealistic illustration.
Illustrative UK workplace scene. Read the practical checks below for responsibilities, evidence and limits. Download image · Download smaller image · Download print PDF
  1. Exact formulation

    Establish the formulation, SDS, task, quantities and relevant routes. Consider removing the solvent step or validating a demonstrably lower-risk process while checking fire, skin and other new hazards.

  2. Source and transfer controls

    Use suitable closed dispensing and verified source capture, lidded waste and clean/dirty boundaries. Control skin and hand-to-mouth routes as well as inhalation.

  3. Actual exposure history

    Record relevant work duration, changes, controls and incidents. Treat measurements in their sampling and task context; a single result cannot prove the cause of an individual’s symptoms.

  4. Sensation and movement

    Peripheral nerve problems can affect feeling or muscle movement. These conceptual labels are not a nerve-conduction test, a body-map diagnosis or proof of workplace causation.

  5. Confidential assessment

    Support appropriate clinical assessment and share necessary factual exposure information through the agreed confidential route. Symptoms may have several occupational or non-work causes.

  6. Safe assignment and review

    Review safe grip, movement and safety-critical demands with the worker and relevant advice while exposure controls are corrected. Use the page’s escalation arrangements for urgent concerns.

Read the complete controls: ERICPD planning prompts

Discipline verifies and sustains all the controls; it is not a separate substitute for them.

Toxic Peripheral Neuropathy — ERICPD planning prompts
Prompt or levelComplete task-specific example
EliminateRemove the solvent-cleaning step by using pre-cleaned parts or a process that needs no chemical wipe.
ReduceTrial a product or method with demonstrably lower neurological and overall health risk, checking the exact formulation, new skin/fire hazards and cleaning performance.
IsolateUse a closed dispenser and suitable local exhaust ventilation at the emission point, with lidded waste and a defined clean zone; prevent solvent transfer to adjacent benches.
ControlLimit quantity and exposed time, train the actual method and spill response, keep food/phones out of the dirty area and investigate early symptoms without assuming a diagnosis.
PPESelect gloves for the specific product and breakthrough time, eye/clothing protection, and suitable RPE only if residual inhalation risk remains after source control.
DisciplineLimit quantity and exposed time, train the actual method and spill response, keep food/phones out of the dirty area and investigate early symptoms without assuming a diagnosis. The COSHH owner checks observed work, exposure data and suitable surveillance advice; new symptoms or uncontrolled exposure trigger review and care. Discipline sustains every control level: verify elimination and substitution decisions, inspect and maintain physical controls, check operating arrangements and residual PPE, investigate defects and worker feedback, and verify corrective action before closure.
Read the complete controls: ESEAP effectiveness order

Compare stronger feasible controls while preserving the actual task, checks and release requirements.

Toxic Peripheral Neuropathy — ESEAP effectiveness order
Prompt or levelComplete task-specific example
EliminationRemove the solvent-cleaning step by using pre-cleaned parts or a process that needs no chemical wipe.
SubstitutionTrial a product or method with demonstrably lower neurological and overall health risk, checking the exact formulation, new skin/fire hazards and cleaning performance.
Engineering controlsUse a closed dispenser and suitable local exhaust ventilation at the emission point, with lidded waste and a defined clean zone; prevent solvent transfer to adjacent benches.
Administrative controlsLimit quantity and exposed time, train the actual method and spill response, keep food/phones out of the dirty area and investigate early symptoms without assuming a diagnosis.
PPESelect gloves for the specific product and breakthrough time, eye/clothing protection, and suitable RPE only if residual inhalation risk remains after source control.

Gloves must suit the exact formulation and contact time; RPE is conditional on the competent assessment, not prescribed by a generic icon.

What control standard is expected under COSHH?

GB COSHH 2002 and NI COSHH 2003 require prevention or adequate control of hazardous exposure; use elimination and source controls before relying on gloves or respirators.

Approve the actual product and method, not a generic chemical family. An SDS informs the assessment but is not the assessment. Substitute where feasible, enclose or capture releases, control contaminated rags and surfaces, select gloves for the actual substance and contact time, and provide hygiene and emergency arrangements.

A workplace exposure limit (WEL), where one exists, is substance-specific, airborne and time-averaged. Check current EH40 and the applicable GB or NI legal position before using a value. Being below a WEL does not prove skin exposure is controlled or health surveillance unnecessary. Decide monitoring and surveillance from the real risk, with competent interpretation.

For a product with a confirmed neurotoxic constituent, the assessor starts with the exact formulation and cleaning task. Remove the chemical step if the finish allows; otherwise validate a lower-risk product before specifying a closed dispenser and suitable local exhaust ventilation. A safety data sheet informs that decision but does not establish exposure or control effectiveness on its own.

Where the assessment calls for monitoring or health surveillance, competent specialists should interpret representative results and protect individual health information. A spill, failed capture or new symptom triggers prompt care and control review. The detailed five-level and ERICPD example names the owner, checks and stop condition for each measure; the HSE control principles put process and engineering measures ahead of PPE.

When should toxic neuropathy risk be escalated?

Stop uncontrolled exposure. Suspected acute poisoning needs immediate medical advice even without severe symptoms; stroke signs or severe illness need 999. Gradual new nerve symptoms need GP assessment while the workplace reviews controls.

A suspected harmful chemical contact needs prompt medical advice by the country-specific route above; do not use symptom severity as the gate. A serious release, collapse or stroke-like change needs 999 and safe isolation without unprotected rescue. A worker with new tingling or weakness should not keep doing an uncontrolled exposure task while waiting for proof of cause. Competent advice sets temporary task controls and any clinical review.

A toxic-neuropathy diagnosis is not automatically reportable under GB RIDDOR. NI RIDDOR 1997 Schedule 3 item 34 specifically lists peripheral neuropathy with work involving n-hexane or methyl n-butyl ketone; the employer checks written doctor diagnosis and current associated work activity; a self-employed person checks doctor notification and the same activity test. Check other incident criteria separately and record the decision. Reporting does not replace care, COSHH control or confidential health handling.

SituationImmediate actionWho should be involved
Sudden one-sided weakness, face or speech changeCall 999 immediately.Emergency services; supervisor secures work area.
Possible harmful chemical contact, inhalation or swallowing, even without severe symptomsStop and isolate safely; seek immediate medical advice by the GB or NI poisoning route. Call 999 for severe illness or stroke signs; no unprotected rescue.Emergency services/urgent clinician and first aider; share SDS without delaying care.
New tingling, numbness or grip/balance changePause uncontrolled exposure, advise GP assessment and review safety-critical task.Worker, supervisor, OH and competent assessor.
Unknown substance or missing SDSHold use and identify product and actual process.Purchaser/supplier and competent COSHH assessor.
LEV, glove or RPE unsuitableStop the affected exposure-producing step and arrange repair or replacement.Supervisor, maintenance and occupational hygienist as needed.
Monitoring or surveillance concernSeek competent interpretation; review exposure and other affected workers.Hygienist/OH with privacy controls.
Possible reportable eventGB and NI rules differ. NI item 34 requires the specified neuropathy/activity pairing and doctor notification; symptoms alone are not a disease report.Competent reporting lead, with documented rationale.

Where does toxic neuropathy prevention fail?

Prevention fails when organisations underestimate skin exposure, rely on smell, ignore subtle symptoms or treat RPE as the main control.

Control failures can hide in open solvent rags, an extraction hood positioned for another task, softened gloves, product substitution, shared spaces and maintenance work. Dizziness during solvent use is an acute warning, not evidence of chronic neuropathy.

Compare the written COSHH assessment with work as done. Check exposure routes, product identity, duration, capture, cleaning and worker reports. Investigate promptly without making a clinical attribution from the symptoms alone.

Failure or weak practiceHow it developsWhat good looks like
Smell used as warningWorkers stay until odour becomes strong.Use exposure assessment, ventilation control and monitoring.
Skin exposure ignoredSoaked gloves, sleeves or rags create absorption risk.Select chemical-resistant gloves and clean handling.
Generic COSHH sheetAssessment does not match product, task or duration.Task-specific COSHH with SDS and observation.
LEV not suited to taskSpray booth controls are assumed to protect bench cleaning.Match capture method to source and breathing zone.
Symptoms dismissedEarly tingling or weakness is treated as personal.Report, remove exposure and review controls.
RPE over-relied onRespirator issued without source reduction or monitoring.Substitution, enclosure, LEV and fit-tested RPE only where needed.
No learning from monitoringResults are filed without control changes.Competent interpretation and verified actions.

What evidence shows toxic peripheral neuropathy risk is controlled?

Retain product identity, SDS, task exposure routes, control verification, monitoring and incident facts. Keep individual symptoms and diagnosis in a restricted clinical route while documenting necessary task adjustments.

Evidence itemWhat it should showAssurance question
COSHH assessmentSubstance identity, routes, WELs, task duration and vulnerable groups are considered.Does the assessment match work as done?
SDS and product reviewNeurotoxic ingredients and control advice are understood.Has substitution been considered?
Exposure monitoringAir monitoring or biological monitoring is used where uncertainty or risk warrants it.Are results interpreted by competent people?
LEV recordsLEV is suitable, tested, maintained and checked before use.Does capture protect the breathing zone?
Glove/PPE assessmentMaterial, breakthrough time, fit and contamination route are controlled.Are gloves task-specific rather than generic?
Health surveillanceProgramme exists where risk criteria require it.Are findings acted on confidentially and promptly?
TrainingWorkers recognise symptoms, routes, hygiene and stop-work triggers.Can workers explain why controls matter?
Action close-outDefects, symptoms and monitoring findings lead to verified improvement.Are repeated signals reduced?

How should toxic peripheral neuropathy be assured?

Sample whether substitutes, enclosure, LEV, hygiene and RPE work during real tasks. Investigate trends in exposure or new symptoms without waiting for a confirmed occupational diagnosis.

Assurance levelWhat to checkWhat good looks like
User checksWorkers check LEV, containers, gloves, RPE and hygiene before use.Defects stop or pause work.
Supervisor checksTask duration, exposure controls and waste practices are observed.Work-as-done matches COSHH assessment.
Occupational hygieneMonitoring confirms exposure assumptions.Results drive control changes.
Occupational healthHealth signals are interpreted confidentially and acted on.Workers are protected from further harmful exposure.
Leadership reviewNeurotoxic substances and surveillance trends are reviewed.Resources are provided for substitution and engineering control.

How can the hierarchy of controls reduce neurotoxic exposures that can damage peripheral nerves?

For this example, remove or redesign the exposure first; use lower-order controls only for the risk that remains. The example is a planning aid, not approval of a live task.

For Northern Ireland work, use this five-level framework to plan controls, then verify the applicable NI duties and HSENI guidance; HSE sources cited here state GB guidance.

Worked scenario: Repeated cleaning with an adhesive remover whose current safety data sheet confirms a neurotoxic solvent ingredient. The HSE five-level hierarchy order elimination, substitution, engineering, administrative controls and PPE. HSE COSHH assessment supplies the topic context. ERICPD maps elimination to elimination, Reduce to substitution and source reduction, Isolate to engineered separation, Control to engineering and administrative arrangements, and PPE to residual personal protection. Discipline is the continuing check, maintenance, supervision and learning that keeps every chosen level effective; it is not blame or a replacement for design controls. For each row, the owner must show why any stronger feasible measure was not chosen, check the residual risk and hold work when the stated control fails. Feasibility test: A surface finish may require chemical cleaning; the product owner must show why no-solvent and lower-risk methods failed before relying on capture and residual PPE.

ERICPD Discipline in this example: The COSHH owner reviews product changes, LEV checks and exposure evidence, observes work, and stops informal reintroduction of the old solvent. After a change, the supervisor verifies the strongest installed control at the workface and records any remaining exposure. If elimination or substitution was rejected, record the task-specific reason and revisit it when the process, equipment or site changes.

What can a voluntary management system add?

A management system can help assign owners, check live controls and correct failures, but it cannot certify that this particular task is lawful or safe. HSE explains the voluntary ISO 45001 context and the real task evidence remains decisive.

For this topic, check the substance and process, source controls, exposure evidence, symptom-reporting route and corrective action. The direct HSE topic guidance supplies the control context. Check the applicable GB or NI duty and the actual work before deciding that a control is effective. This is a SHARE management application, not an interpretation of an ISO clause.

What training and competence are needed?

Competence is a sound decision demonstrated in the real task, assessed by an appropriate person and revisited when conditions change.

Use a solvent task and new tingling/weakness scenario. Workers identify the SDS and stop/report route; supervisors control exposure without deciding the diagnosis; hygienists test the substance and control; clinicians assess causes and fitness. Reassess after a product substitution or abnormal exposure.

RoleLearning to testDemonstrationAssessor and evidenceReassess when
WorkersIdentify task chemicals, early symptoms and the stop/report route.Demonstrate SDS access and safe handover.Supervisor: observed task and concern response.New substance or symptom concern.
SupervisorsHold unsafe exposure and adjust work pending specialist review.Run an early-symptom and control-failure scenario.Manager: action log and restricted referral.Control failure or changed method.
COSHH assessors and hygienistsVerify exact agents, WELs, combined routes and LEV/RPE effectiveness.Defend sampling, maintenance and substitution decisions.Technical lead: signed assessment and control evidence.New product, result or process.
Occupational health and cliniciansEvaluate diagnosis, alternative causes and work function.Give confidential, task-relevant advice.Clinical lead: restricted case review.Clinical or task change.
Senior managersResource prevention and verify the learning loop.Challenge repeated symptoms or weak monitoring.Safety lead: assurance sample and closed actions.Trend or significant event.

Which acronyms and terms are useful for toxic peripheral neuropathy?

These are the clinical and workplace terms used on this page.

AcronymMeaningPlain-English use
A&EAccident and EmergencyEmergency hospital department for urgent medical care.
COSHHControl of Substances Hazardous to HealthGB COSHH 2002; NI has separate COSHH 2003 regulations.
GPGeneral PractitionerPrimary care doctor and common health signposting route.
HSEHealth and Safety ExecutiveGreat Britain regulator and official guidance source.
NHSNational Health ServiceUK public health service and official health guidance source.
OHOccupational HealthCompetent clinical advice route focused on work and health.
PPEPersonal Protective EquipmentEquipment worn where higher-order controls do not remove risk.
RIDDORReporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013GB 2013 reporting regulations; NI has a separate 1997 regime.
EH40Workplace Exposure LimitsHSE limits register approved for GB and NI COSHH use; verify current value.
LEVLocal Exhaust VentilationEngineering control used to capture airborne contaminants at source.
RPERespiratory Protective EquipmentRespiratory protection selected where other controls do not adequately control inhalation exposure.
SDSSafety Data SheetSupplier hazard, control, first-aid and emergency information for substances.
WELWorkplace Exposure LimitAirborne exposure limit averaged over a specified reference period.
Distal neuropathyNerve damage often affecting feet or hands first.Symptoms need clinical assessment; do not infer the cause at work.
Exposure routeThe way a substance reaches the body, such as breathing it or skin contact.Assess the actual product and task before choosing controls.